Carregant...
Targeted therapy for metastatic renal cell carcinoma
BACKGROUND: Several comparative randomised controlled trials (RCTs) have been performed including combinations of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors since the publication of a Cochrane Review on targeted therapy for metastatic renal cell carcinoma (mRCC) in 2008. This...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094280/ https://ncbi.nlm.nih.gov/pubmed/33058158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012796.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|